PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
3.94%
ROE of 3.94% versus zero median in Medical - Pharmaceuticals. Walter Schloss would verify if slight profitability advantage matters long-term.
1.35%
ROA of 1.35% while Medical - Pharmaceuticals median is zero. Peter Lynch would see if minimal profitability can widen over time.
4.44%
ROCE of 4.44% while Medical - Pharmaceuticals median is zero. Walter Schloss would see if moderate profitability can widen vs. peers.
18.81%
Gross margin below 50% of Medical - Pharmaceuticals median of 37.91%. Jim Chanos would suspect flawed products or pricing.
2.76%
Operating margin exceeding 1.5x Medical - Pharmaceuticals median of 0.95%. Joel Greenblatt would study if unique processes or brand lift margins.
1.82%
Net margin 1.25-1.5x Medical - Pharmaceuticals median of 1.29%. Mohnish Pabrai would check if management’s strategy consistently produces high net profits.